Crescendo Biologics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Crescendo Biologics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10869
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company’s pipeline includes humabody programs targeting oncology. It practises in the antibody discoveries and development, which include CAT, medimmune, morphosys and GSK. Crescendo develops a transformational Humabody-based topical biologic for psoriasis, which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The company’s oncology programmes produce novel therapeutics that capitalizes on advantages of the Humabody VH format. Crescendo is headquartered in Cambridge, the UK.

Crescendo Biologics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Crescendo Biologics Raises USD69.1 Million in Series B Venture Financing 10
Crescendo Biologics Raises Funds through Venture Financing 12
Crescendo Biologics Raises US$3.3 Million In Series A Financing 13
Crescendo Biologics Raises US$28 Million In Series A Financing 14
Licensing Agreements 16
Takeda Pharma Exercises Option for Licensing Agreement with Crescendo Biologics 16
Zai Lab Enters into Licensing Agreement with Crescendo Biologics 17
Crescendo Biologics Ltd – Key Competitors 18
Crescendo Biologics Ltd – Key Employees 19
Crescendo Biologics Ltd – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jun 14, 2017: Crescendo Biologics Appoints Edward J. Stewart as Chief Business Officer 21
Apr 03, 2017: Crescendo Biologics Appoints Philip Bland-Ward as Chief Scientific Officer 22
Other Significant Developments 23
Aug 15, 2018: Crescendo Biologics reaches technical milestone for a second target in strategic collaboration with Takeda 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Crescendo Biologics Raises USD69.1 Million in Series B Venture Financing 10
Crescendo Biologics Raises Funds through Venture Financing 12
Crescendo Biologics Raises US$3.3 Million In Series A Financing 13
Crescendo Biologics Raises US$28 Million In Series A Financing 14
Takeda Pharma Exercises Option for Licensing Agreement with Crescendo Biologics 16
Zai Lab Enters into Licensing Agreement with Crescendo Biologics 17
Crescendo Biologics Ltd, Key Competitors 18
Crescendo Biologics Ltd, Key Employees 19

List of Figures
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Crescendo Biologics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Crescendo Biologics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ATCC-製薬・医療分野:企業M&A・提携分析
    Summary ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other ma …
  • VOXX International Corporation:企業の戦略・SWOT・財務情報
    VOXX International Corporation - Strategy, SWOT and Corporate Finance Report Summary VOXX International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Berkshire Hathaway Energy Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Berkshire Hathaway Energy Company (BHE) a subsidiary of Berkshire Hathaway Inc., generates, transmits, stores, distributes, and supplies electricity; and procures, transports, distributes and sells natural gas through its subsidiaries. It generates power through diversified energy sources su …
  • Bando Chemical Industries Ltd (5195):企業の財務・戦略的SWOT分析
    Bando Chemical Industries Ltd (5195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cohort plc:企業の戦略・SWOT・財務情報
    Cohort plc - Strategy, SWOT and Corporate Finance Report Summary Cohort plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • University of Cambridge:企業のM&A・事業提携・投資動向
    University of Cambridge - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Cambridge Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • China Overseas Land & Investment Limited:企業の戦略・SWOT・財務情報
    China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report Summary China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Ostfold Energi AS:企業の戦略的SWOT分析
    Ostfold Energi AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Lycamobile UK Limited:企業の戦略的SWOT分析
    Lycamobile UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Showa Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The North West Company Inc. (NWC):企業の財務・戦略的SWOT分析
    The North West Company Inc. (NWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Electromagnetic Geoservices ASA (EMGS):石油・ガス:M&Aディール及び事業提携情報
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, z …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • ALLETE, Inc.:企業の戦略・SWOT・財務情報
    ALLETE, Inc. - Strategy, SWOT and Corporate Finance Report Summary ALLETE, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mtr Corporation Ltd:企業の戦略・SWOT・財務分析
    Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mtr Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Conatus Pharmaceuticals Inc (CNAT):製薬・医療:M&Aディール及び事業提携情報
    Summary Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the act …
  • Penn United Technologies, Inc.:企業の戦略・SWOT・財務情報
    Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆